SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

21 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 1041.08 millions rose by 42.27% from Rs. 731.75 millions.The Net Profit of the company reported a remarkable increase of 365.65% to Rs. 64.40  millions  from Rs. 13.83 millions in previous same quarter.The company reported a good operating profit of 153.27 millions compared to 93.76 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1041.08 731.75 42.27 3294.94 3036.29 8.52 3294.94 3036.29 8.52
Other Income 16.47 8.49 93.99 45.06 24.49 83.99 45.06 24.49 83.99
PBIDT 153.27 93.76 63.47 424.40 392.62 8.09 424.40 392.62 8.09
Interest 14.31 29.32 -51.19 83.06 108.86 -23.70 83.06 108.86 -23.70
PBDT 138.96 64.44 115.64 341.34 231.95 47.16 341.34 231.95 47.16
Depreciation 38.77 38.94 -0.44 148.37 146.14 1.53 148.37 146.14 1.53
PBT 100.19 25.50 292.90 192.97 85.81 124.88 192.97 85.81 124.88
TAX 35.79 11.67 206.68 62.84 29.64 112.01 62.84 29.64 112.01
Deferred Tax 16.60 33.07 -49.80 28.84 29.47 -2.14 28.84 29.47 -2.14
PAT 64.40 13.83 365.65 130.13 56.17 131.67 130.13 56.17 131.67
Equity 162.42 162.42 0.00 162.42 162.42 0.00 162.42 162.42 0.00
PBIDTM(%) 14.72 12.81 14.90 12.88 12.93 -0.39 12.88 12.93 -0.39

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×